Recent Finacing
Recent Raise
RadioMedix is a clinical-stage biotech developing targeted radiopharmaceutical diagnostics and targeted alpha therapies for cancers, marketing FDA‑approved 64Cu‑DOTATATE, and operating preclinical, discovery, and cGMP manufacturing facilities in Humble, Texas.
